Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Zhongyuan Biological Technology Research Institute is a specialized research and development entity under the China National Pharmaceutical Group (Sinopharm). Located in Zhengzhou, Henan, the institute serves as a regional hub for biotechnology innovation, focusing on the development of vaccines, diagnostic reagents, and advanced therapeutic modalities such as cell and gene therapies. It integrates basic research with pilot-scale production to accelerate the translation of scientific discoveries into clinical products. The institute plays a pivotal role in Sinopharm's strategy to strengthen the biological industry chain in the Central Plains region of China. By leveraging the parent group's extensive resources, it contributes to national public health security and the advancement of precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Zhongyuan Biological Technology Research Institute.